TransDigm Executive Sells Approximately $31.5 Million in Shares Through 10b5-1 Plan for Significant Cash Generation

Fortuna Trust Sells 22,373 Shares After Option Exercise, Net Cash Approximately $25.5 Million

On January 8, 2026, Kevin M. Stein, an officer of TransDigm Group Inc. (TDG), executed a significant stock‐option exercise and subsequent sale through The Fortuna Trust. According to a Form 4 filed on January 9 (local time), Stein exercised 17,373 stock options at an adjusted exercise price of $342.31 per share, acquiring the same number of common shares. He then sold a total of 22,373 common shares in the open market the same day at a weighted‐average price of approximately $1,405.30–$1,413.17 per share. The sale generated gross proceeds of about $31.5 million (≈₩441 billion, 1 USD = 1,400 KRW).

$31.5 Million Sale vs. $6 Million Exercise Cost—Net Cash of $25.5 Million, Yet Large Remaining Stake

The option exercise required an outlay of roughly $6 million (≈₩84 billion), leaving Stein with net cash proceeds of approximately $25.5 million (≈₩357 billion). According to the company’s disclosure, The Fortuna Trust still holds 8,158 indirectly held common shares plus 50,627 shares held via derivatives. Based on current share prices, these remaining holdings are estimated to exceed $80 million (≈₩1.12 trillion). While the transaction may signal short‐term cashing‐out by management, the sizeable residual stake suggests continued long‐term alignment with shareholder interests.

Pre-Announced 10b5-1 Plan Limits Information Asymmetry

This sale was not an impromptu executive divestiture but part of a pre-announced trading plan. A Form 144 filed on June 2, 2025, revealed that The Fortuna Trust U/T/A DTD 06/01/2018 intended to sell 17,373 TransDigm common shares beginning January 8, 2026, under a Rule 10b5-1 trading arrangement managed by Morgan Stanley Smith Barney LLC Executive Financial Services. The disclosure also referenced further sales scheduled for late 2025 and early 2026. Because the transactions followed a pre-set automatic plan, concerns over selective timing based on material non‐public information are largely mitigated.

Investor Perspective: Short-Term Pressure vs. Long-Term Alignment

From an investor standpoint, a multi-million-dollar insider sale at prices above $1,400 per share could exert psychological pressure on the stock in the near term. The wide gap between the exercise price (≈$342) and the sale price may lead market participants to view this range as an opportunistic profit-taking level. However, given the substantial remaining holdings and the predetermined Rule 10b5-1 framework, the transaction is more likely driven by liquidity management and portfolio diversification than by negative signals about corporate governance or fundamentals.

Transaction Overview

Date	Seller	Transaction Type	Options Exercised	Exercise Price	Exercise Cost	Common Shares Sold	Sale Price Range	Sale Proceeds	Prior Disclosure
2026-01-08	Kevin M. Stein (via The Fortuna Trust)	Option exercise and sale (Form 4)	17,373 shares	$342.31	~$6 million (₩84 billion)	22,373 shares	$1,405.30–$1,413.17	~$31.5 million (₩441 billion)	Form 144 on 2025-06-02 (10b5-1 plan for 17,373 shares, ~$24.06 million)